World Heart Federation Consensus on Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)
Transthyretin amyloid cardiomyopathy (ATTR-CM) is a progressive and fatal condition that requires early diagnosis, management, and specific treatment. The availability of new disease-modifying therapies has made successful treatment a reality. Transthyretin amyloid cardiomyopathy can be either age-r...
Váldodahkkit: | , , , , , , , , , , , , , , , , , , |
---|---|
Materiálatiipa: | Artihkal |
Giella: | English |
Almmustuhtton: |
Ubiquity Press
2023-10-01
|
Ráidu: | Global Heart |
Fáttát: | |
Liŋkkat: | https://account.globalheartjournal.com/index.php/up-j-gh/article/view/1262 |